Delaware continues to see a welcome decline in Covid-19 cases and hospitalizations, the Delaware Division of Public Health reported.
Driving the surge in cases is the Omicron variant, which now accounts for more than nine out of 10 new cases, based on test samples.
In the Sunday report, DPH reported 560 current hospitalizations, up by five from the previous day, including 56 individuals in critical condition. That was well below the more than 700 hospital stays reported earlier, but above the January 2021 peak of 474.
Weekly figures as Jan. 20
Covid-19 cases and hospitalizations
- Total positive cases since March 11, 2020: 236,022
- Seven-day average of new positive cases: 2,006.6, down from 3,187.6 last week.
- The seven-day average for the percentage of total positive tests: 27.2%, down from 31% last week
- Hospitalizations: 606, a decrease of 123 from last week; critically ill: 64, a decrease of five from last week
- Total Covid-19 deaths: 2,457
- Total Covid-19 deaths reported since last week: 61 including 21 from a review of vital statistics records
Covid-19 vaccinations
- Total number of doses administered in Delaware: 1,620,971
- Percentage of Delawareans 5+ who received at least one dose (CDC data) 84.2%
- Percentage of Delawareans 12+ who have received at least one dose (CDC data): 89.5%
- Percentage of Delawareans 18+ who received at least one dose (CDC data): 91.5%
- Percent of Delawareans who are fully vaccinated (CDC data): 65.7%
COVID-19 Case Vaccination Status Report
The following reports capture a weekly breakdown of vaccination status for cases, deaths, and hospitalizations from Jan.10 – Jan.16.
| Weekly Overview (1/10/22- 1/16/22) |
|||||||||||||||||
| Unvaccinated Cases | |||||||||||||||||
| Total Unvaccinated / Partially Vaccinated Cases | 10,663 | ||||||||||||||||
| Total Cases | 18,910 | ||||||||||||||||
| Percent of Unvaccinated / Partially Vaccinated Cases | 56% | ||||||||||||||||
| Hospitalizations | |||||||||||||||||
| Unvaccinated / Partially Vaccinated Hospitalized Cases | 263 | ||||||||||||||||
| Total Hospitalized Cases | 432 | ||||||||||||||||
| Percent of Unvaccinated / Partially Vaccinated Hospitalized Cases | 61% | ||||||||||||||||
| Deaths | |||||||||||||||||
| Unvaccinated / Partially Vaccinated COVID-19 Deaths | 23 | ||||||||||||||||
| Total COVID-19 Deaths | 35 | ||||||||||||||||
| Percent of Unvaccinated / Partially Vaccinated COVID-19 Deaths | 66% |
| Weekly Overview (1/10/22- 1/16/22) |
|||||||||||||||||
| Unvaccinated Cases | |||||||||||||||||
| Total Unvaccinated / Partially Vaccinated Cases | 10663 | ||||||||||||||||
| Total Cases | 18910 | ||||||||||||||||
| Percent of Unvaccinated / Partially Vaccinated Cases | 56% | ||||||||||||||||
| Hospitalizations | |||||||||||||||||
| Unvaccinated / Partially Vaccinated Hospitalized Cases | 263 | ||||||||||||||||
| Total Hospitalized Cases | 432 | ||||||||||||||||
| Percent of Unvaccinated / Partially Vaccinated Hospitalized Cases | 61% | ||||||||||||||||
| Deaths | |||||||||||||||||
| Unvaccinated / Partially Vaccinated COVID-19 Deaths | 23 | ||||||||||||||||
| Total COVID-19 Deaths | 35 | ||||||||||||||||
| Percent of Unvaccinated / Partially Vaccinated COVID-19 Deaths | 66% |
Breakthrough Cases (cumulative since the beginning of vaccinations
- Total breakthrough cases: 16,469, or 2.84% of fully vaccinated individuals
- Total breakthrough hospitalizations: 197
- Total breakthrough deaths: 176
A breakthrough case is defined as testing positive for COVID-19 after an individual has been fully vaccinated for two weeks or more. Data may be updated as additional information is received.
COVID-19 Variant Cases in Delaware
Of the samples collected during the week of Dec. 31 – Jan. 6, the Omicron variant represented 94.5% of cases sequenced for a variant of concern, variant of interest, or variant being monitored. The remaining 5.5% of sequenced cases were identified as Delta.
As a reminder, DPH is now providing variant data based on sample collection date rather than sequencing date, due to the length of time between sample collection (when a person is tested) and when samples are sequenced by laboratories, which can take two weeks or longer. This will more accurately reflect the proportion of specific variants that are circulating in the community at various points in time.
The Delaware Public Health Laboratory and other laboratories regularly monitor for the presence of Covid-19 variants, including Delta and Omicron, through routine genomic sequencing of test specimens. Genome sequencing is a public health surveillance tool used to monitor the prevalence of Covid-19 variants. It is not used to diagnose individuals with a specific strain of COVID-19, as treatment recommendations do not differ based on variant strains.
